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Investing in doctors - follow up study of UK Cystic Fibrosis Trust 
training fellows 
J. Wil l iams 1, J. Tyt~elF 
Department of Paediatrics ~, Heartla~uls Hospital, Birmingham, UK, Department of 
Paediatrics ~, Royal United Hospital, Bath, UK
From 1985 until 2CO2 the UK Cystic Fibrosis Trust (CFF) concluded that one way 
of improving cystic fibrosis services would be to invest ha training future consultant 
paediatricians and adult physicians in CF. At  the begimaing of this scheme, 
traditional routes to training as a consultant (usually a min imum of 8 years) included 
2 years research, aiming for a higher degree. 
CF fellowships were awarded to units designated as 'CF centres' (having at least 50 
patients) and were spread tilt oughout he UK mad Nor them Ireland. 
How effective was this investment in people? How many of those trained by the 
Tmst are still working in the field? 
We attempted to answer these questions by tracing those who had CFT fellowships 
to complete a short questionnaire. We have identified 50 fellows so far. To date 21 
have responded. 
There were 5 adult physicians and 16 paediatricians. Twelve have obtained a higher 
degree mad fellows achieved a mean of 3.4 publications (range 010)  during the 
fellowship. Two thirds are still looking after CF patients, of whom 5 are in CF 
centers. Ctarent research sessions are only available to those in Centres but these 
fellows have 143 publications between them. 
The CF Trust has spent a lot on training these fellows. Without exception all fel lows 
would recommend such a training fel lowship roviding the research element was 
wel l  planned and protected from clinical work. Paediatricians who were no longer 
working ha CF still felt their t ime was invaluable, particularly training ha research 
and multidisciplinary team working. 
With the proposed changes to UK  consultant training, it is unl ikely that future 
paediatricians and chest pbysicians especially in District General Hospitals wi l l  
have exposure to such an in depth training this may in tuna signiBcantly affect the 
shared care models currently provided. 
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Is there a place for telomodicino while awaiting transplantation? 
O.M. Wilkinson, F. Duncan S kingle, J.A. Pt3'or, M.E. Hodson 
Department of Cystic Fibrosis, Royal Brorr~ton & Ha@eM NHS Trust, Sydney 
Street, Lotulon SW3 6NP 
Royal Brompton has 650 adult patients with cystic fibrosis (CF), 2.6% are on the 
transplant wait ing list. These patients attend outpatient clinics regularly, and may 
spend t ime in hospital. This can adversely impact on daily living, quality of l i fe and 
cause stress. Technological advances in communication have allowed telemedicine 
l inks to bridge the gap between home and hospital. 
A ims:  A study was undertaken to see the feasibility of providing adequate support 
using this technology, so el iminat ing travel to clinics. The impact of telemedicine 
on quality of life, anxiety, depression, admission to hospital and clinic attendance 
was studied. Measurements were taken at 0, 2, 4 and 6 monthly intervals. 
Methods:  Sixteen patients were randomised to telemedicine (8) or a control group 
(8). 5 failed to complete the baseline assessment (4 died: l  declined). 11 patients 
completed the baseline assessment 3 of whom then had successful transplants. 
Patients in the telemedicine group l inked up weekly via an ISDN l ine using a 
television at home. Participants answered a satisfaction questiomaaire after a 6 
month period. Anxiety levels were measured before and after each l ink up and 
before and after each clinic. Carets were asked to complete a coping analysis 
questiomaaire. 
Results: Participants found telemedicine asy to use, the l ink up was helpful 
making them feel less isolated. The majority (80%) found it unobtrusive and 
preferred telemedicine l ink ups to either clinic appointments or telephone 
assessments. There were no significant differences ha anxiety and depression levels 
between the groups at baseline or on completion of the study. 
Conclusions: The study was a pilot and further large scale studies are needed. 
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Virtual PaSent EducaSon Days: a Web-based educational tool 
L. Hazle 1, D.A. Evans ~ 
~Cystic Fibrosis Fou~ulatio~ Bethesda, MD, USA, 2Genentech, Inc., South Sa  
Francisco, CA, USA 
The Cystic Fibrosis (CF) Foundation promotes quality improvement efforts to 
optimize patient outcomes. In this regard, education of cystic fibrosis patients has 
become a primary focus to increase kimwledge of and adherence to a complex 
treatment regimen. The World Wide Web has emerged as a powerful educational 
tool for people seeking disease related information. The technology of l ive 
webcasts allows medical professionals to disseminate knowledge to their colleagues 
and patients at a distance in real time, without requiring travel. Of  particular 
relevance to the CF community, patients can participate in Web based activities 
without r isking the transmission of pathogens. 
The CF Foundation, with the support of an unrestricted educational grant from 
Genentech, Inc., has developed Virtual Patient Education Days: interactive, 
educational webcasts featuring CF experts discussing the disease, treatments, and 
cutting edge research. Dur ing each l ive audiovisual presentation, participants e 
mail  questions to the presenters to answer during the broadcast. Questions not 
addressed uring the l ive broadcast are answered ha writ ing on the CF Foundation's 
website, where webcasts are archived and readily available to people around the 
world. 
Since its inception, f ive webcast s have reached more than 3800 l ive participants ha 
all 50 states and over 42 countries, and more than 18,(~) people have viewed an 
archived webcast on the CF Foundation's website. Program topics have covered 
infection control, nutrition, standards of CF care, and updates on emerging 
therapies. Thus, the Virtual Patient Education Day program has served as a highly 
interactive, xpert dr iven educational resource that empowers patients and famil ies 
to optimize clinical outcomes. 
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Podiatric living donor lobar vs. cadaveric lung: quality of life 
before/after transplantaSon 
L.K. Fukushima 1,M.V. Horn 1, A.L. Quiltner:, V.A. Starnes 1,M.S. Woo 1 
iChiMrens Hospital Los Angeles, 2Universiiy of Miami, USA 
Is CF quality of l ife (CFQ R) different between l iving donor lobar (LL) and 
cadaveric lung (CL) transplant ( x) pts? We administered the CFQ R to all CF lung 
tx candidates at our center (2CO3 2CO4). CFQ R were computer scored (score 0 
1CO; 1CO better QoL). Analysis was by Student's t4est and Fisher's exact. 19 CF 
pts (14.6+3.8 yrs; 5M:14F) were accepted for lung tx at our center (6 LL;  13 CL). 
LL pts were considered too il l to survive for cadaveric organs. There was no 
difference in LL vs CL candidates in age (p 0.20), gender distribution (p 0.13), 
height (p~).66), weight (p 0.64), FEV 1 (p~).69), FEF~575 ¢ (p 0.70), FVC 
(p~).77), oxygen use (p 1.0), sputum bacteria (p 0.56) and ambulatory status 
(p~).13). On CFQR,  LL  candidates had lower Physical (7.9+10.7 vs 29.4+23.9, 
p 0.02) and Eating (31.5+21.6 vs 63.0+29.8, p~).02) scores compared to CL. There 
was no difference for LL vs CL in domains of Emotion (p~).67), Social (p 0.77), 
Body Image (p~).95), Treatment Burden (p~).40), Respiratory (p 0.92) or 
Digestion (p 0.55). 9/19 (47%) had lung tx during the study period (6 LL:3 CL). 
Al l  recipients reported marked improvement in all domains <3 mo post tx. There 
was no difference (LL vs CL) in CFQR Physical (p~).66), Emotion (p~).61), 
Social (p 0.56), Body Image (p 0.15), Eat ing (p 0.19), Treatment Burden 
(p~).34), Respiratory (p 0.72) and Digestion (p~).60) domains. We conclude that 
pediatric LL candidates have lower CFQ R scores in Physical and Eating domains 
compared to CL, despite similar cl inical findings in both groups. Both LL  mad CL 
recipients had improved CFQR measurements after tx. We speculate that low CFQ 
R scores in Physical mad Eating domains may be indications for CF lung tx referral. 
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